The most common adverse reactions (≥25%) in adult patients with NSCLC are vision disorders, nausea, diarrhea, vomiting, edema, constipation, elevated transaminases, fatigue, decreased appetite, upper respiratory infection, dizziness, and neuropathy.
The most common adverse reactions (≥35%) in patients with ALCL are diarrhea, vomiting, nausea, vision disorder, headache, musculoskeletal pain, stomatitis, fatigue, decreased appetite, pyrexia, abdominal pain, cough, and pruritus. Grade 3-4 laboratory abnormalities (≥15%) are neutropenia, lymphopenia, and thrombocytopenia.
The most common adverse reactions (≥35%) in adult patients with IMT are vision disorders, nausea, and edema.The most common adverse reactions (≥35%) in pediatric patients with IMT are vomiting, nausea, diarrhea, abdominal pain, rash, vision disorder, upper respiratory tract infection, cough, pyrexia, musculoskeletal pain, fatigue, edema, constipation, and headache.
from FDA,2023.09
The information and clinical feedback on the use of crizotinib should be compreh···【more】
Release date:2025-04-08Recommended:43
Understanding the characteristics of drugs and how to use them appropriately is ···【more】
Release date:2025-04-07Recommended:36
This article focuses on the clinical features and cost analysis of the drug criz···【more】
Release date:2025-04-07Recommended:46